MOTS-C is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial. MOTS-C is not fda-approved. listed by fda as unlawful for compounding. available as research chemical only. As with any research compound, individual responses vary.
Is MOTS-C Safe?
Safety is the most important consideration with any research compound. MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator with a safety profile established through preclinical research.
First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
What Are the Known Side Effects of MOTS-C?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
These effects are based on preclinical data and community reports at standard dosages of 5-10 mg per week. Higher doses generally increase both the likelihood and severity of side effects.
Are MOTS-C Side Effects Dose-Dependent?
Most reported MOTS-C side effects are dose-dependent — meaning they're more likely at higher doses and less likely at the lower end of the 5-10 mg per week range.
This is why starting at the minimum effective dose and titrating up is the standard approach. With a half-life of not established in humans, any adverse effects will typically resolve within a few half-life periods after discontinuation.
What About Long-Term MOTS-C Use?
Long-term safety data for MOTS-C is limited, as with most research peptides. Standard cycles run 8-12 weeks with 8-12 week breaks.
MOTS-C is not fda-approved. listed by fda as unlawful for compounding. available as research chemical only. Extended use beyond recommended cycles should be approached with caution.
Does MOTS-C Interact With Other Compounds?
Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization.
When stacking peptides, be aware that combining multiple compounds increases the total side-effect surface area. Monitor closely when introducing any new compound.
How Can You Minimize MOTS-C Side Effects?
Start at the lower end of the dosage range (5-10 mg per week). Use proper reconstitution and injection technique to minimize injection site reactions. Store correctly (lyophilized at -20°C, reconstituted at 2-8°C) to maintain purity.
Source only from vendors with third-party COA testing — contaminated or mislabeled products are a significant source of unexpected adverse effects.
What Is the Bottom Line on MOTS-C Safety?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial. Overall, MOTS-C is considered well-tolerated at standard research doses.
Read our MOTS-C dosage guide for protocols designed to minimize risk.
Complete Guide
MOTS-c: The Metabolic Mitochondrial Peptide
Related Reading
- MOTS-C Dosage Guide
- MOTS-C Benefits
- MOTS-C Stacking Guide
- MOTS-C Cycle Guide
- MOTS-C Research
- 5-Amino-1MQ Complete Guide
Calculate Your MOTS-C Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MOTS-C.
Open Calculator →Research-Grade Sourcing
If you're going to research MOTS-C, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging. It is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
What is the recommended MOTS-C dosage?
Common dosages: 5-10 mg per week administered 2-3 times weekly via subcutaneous injection. Cycle length: 8-12 weeks with 8-12 week breaks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of MOTS-C?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Is MOTS-C safe?
MOTS-C has shown a favorable safety profile in research. Not FDA-approved. Listed by FDA as unlawful for compounding. Available as research chemical only. All research should follow appropriate safety protocols.